DJIA 17,195.42 221.11 1.30%
NASDAQ 4,566.14 16.91 0.37%
S&P 500 1,994.65 12.35 0.62%
market minute promo

ImmunoGen (NASDAQ: IMGN)

9.49 0.12 (1.23%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IMGN $9.49 1.23%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.35
Previous Close $9.38
Daily Range $9.28 - $9.74
52-Week Range $7.70 - $17.80
Market Cap $815.3M
P/E Ratio -9.77
Dividend (Yield) $0.00 (0.0%)
Volume 1,247,862
Average Daily Volume 1,486,095
Current FY EPS -$0.71

Sector

Healthcare

Industry

Drugs

ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website: http://www.immunogen.com/

News & Commentary

ImmunoGen, Inc. Pushes Forward

With just $4.2 million in royalties from Roche's Kadcyla, investors need to be focused on ImmunoGen's internal pipeline.

ImmunoGen: Analysis Of Earnings Miss

ImmunoGen's (IMGN) CEO Daniel Junius on Q1 2015 Results - Earnings Call Transcript

ImmunoGen (IMGN) Q3 2014 Results - Earnings Call Webcast

ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape

ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape

Immunogen (IMGN) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas: Immunogen (IMGN) Is Today's Strong On High Relative Volume Stock

Today's Weak On High Volume Stock: Immunogen (IMGN)

3 Value Stocks Near 52-Week Lows Worth Buying

These value stocks may be hitting a new 52-week low, but they may not be there for long!

First Week of IMGN November 22nd Options Trading

See More IMGN News...

IMGN's Top Competitors

IMGN $9.49 (1.23%)
Current stock: IMGN
AMGN $161.58 (1.70%)
Current stock: AMGN
GILD $114.22 (3.16%)
Current stock: GILD
BIIB $321.00 (1.89%)
Current stock: BIIB